TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $37,000 | -51.9% | 13,342 | -19.0% | 0.00% | – |
| Q4 2021 | $77,000 | -75.4% | 16,469 | -55.2% | 0.00% | – |
| Q3 2021 | $313,000 | -54.6% | 36,768 | -12.6% | 0.00% | -100.0% |
| Q2 2021 | $690,000 | -28.4% | 42,061 | -3.7% | 0.00% | 0.0% |
| Q1 2021 | $964,000 | -18.9% | 43,659 | +13.6% | 0.00% | -50.0% |
| Q4 2020 | $1,189,000 | +52.2% | 38,448 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $781,000 | +107.2% | 38,448 | +56.5% | 0.00% | 0.0% |
| Q2 2020 | $377,000 | +163.6% | 24,561 | +33.0% | 0.00% | – |
| Q1 2020 | $143,000 | -45.2% | 18,463 | +1.1% | 0.00% | – |
| Q4 2019 | $261,000 | -4.7% | 18,254 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $274,000 | +602.6% | 18,254 | +568.2% | 0.00% | – |
| Q2 2019 | $39,000 | – | 2,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |